She served as president of Aetna’s northeast region and interim president of the southeast region and was responsible for $20 billion in revenue and approximately five million members across the commercial and Medicare segments. Keck previously spent 28 years at Aetna, where she held leadership roles spanning from head of enterprise strategy to head of investor relations, treasury, tax, actuary, controllers and planning. She also combatted long-standing social issues influencing health outcomes, including childhood obesity, housing insecurity and racial inequities. During her tenure at BCBSRI, she drove strategic initiatives around cost and value stewardship, convenience and comprehensive health, and led policy efforts fortifying elements of the Affordable Care Act to ensure all Rhode Islanders have access to quality care. Prior to joining BCBSA in 2021, she served as president and CEO of Blue Cross & Blue Shield of Rhode Island (BCBSRI), the state’s largest health insurer. Keck, a respected leader in the healthcare industry, has built a reputation as an engaged, incisive leader. Today, one in three Americans is covered by the Blue System. Keck is president and chief executive officer of the Blue Cross Blue Shield Association (BCBSA), a national federation of 34 independent, community-based and locally operated Blue Cross and Blue Shield (BCBS) companies. Capabilities & Initiatives Show Capabilities & Initiatives submenu.The BCBS System Show The BCBS System submenu.
Individuals & Families Show Individuals & Families submenu.Member Services Show Member Services submenu.The time has come to unite our efforts to end the devastating impact of these diseases and garner support for our collective goals. Few in the general public, however, know these facts. The science is finally in a place where the question is not if we will find cures, but when. The reality is our diseases and, therefore, our efforts are all linked. While some fight ALS, others fight Parkinson’s disease, Alzheimer’s disease, or multiple sclerosis. Second, we already know that 1 in 15 adults in the developed world will be diagnosed with a neurological disease in their lifetimes. The tools and advocacy model developed by I AM ALS will be made available to other disease organizations to help them raise awareness, increase engagement, and transform and accelerate progress against their diseases. I AM ALS has set out to build a movement that connects patients, caregivers, researchers, clinicians, foundations, corporations and the public in our efforts because we each have a part to play and are stronger when we work together. How we expand our impactįirst, we build a model that can be replicated for every rare disease fight. It is up to us to bring ALS out of the shadows and teach others that taking action for cures can be as simple as telling a neighbor that ALS is deadly and impacts every community. In order to make real, expeditious progress we must change that. Few know what it is and that it can affect anyone, anywhere, at any age. Each of us can speed up our timeline toward cures. Engagementįaster progress toward cures and better health advocacy require building a community in which everyone is empowered and has an integral role in leading the movement. ResourcesĪt I AM ALS, we built a single entry point to help connect patients and their loved ones to existing resources while delivering critical new tools to ensure care and support is there for every step on the ALS journey. Hope transformed into a movement by the dozens of partners, old and new, who share our unceasing drive to make change real for those living with ALS. Our story is hope borne from recent scientific developments. Together, you and me, we are going to cure ALS. My ALS story, however, will not have a typical ending.
0 kommentar(er)
